Wikipedia

Search results

The Superior Benefits of Magnesium and the Whole Food Matrix*

 

Summary

Magnesium (Mg) is an essential nutrient, participating in a variety of body functions and supporting multiple body systems.

Magnesium (Mg) is an essential nutrient, participating in a variety of body functions and supporting multiple body systems. Read on to identify magnesium’s key functions, understand the value of Mg supplementation in a whole food matrix, and get a glimpse of how Mg intake affects various human conditions.

Why is Mg so important? What systems does it support?

Mg is a …

  • Catalyst for many intracellular processes
  • Co-factor in more than 300 enzymes in the body1

Mg is vital for…

  • Supporting protein, DNA, and RNA synthesis
  • Supporting cell growth and reproduction
  • Energy storage and production
  • Stabilization of the cell membrane
  • Maintaining normal nerve and muscle function
  • Muscle contraction
  • Strong bones2

What are the benefits of the whole food matrix?

The Mg ion is very reactive and unstable. Supplementation with Mg in a whole food matrix mimics the way Mg is found in nature, bound to various organic and inorganic compounds such as other minerals, proteins, and peptides.

In what patient profiles should Mg be considered?

Individuals with gastrointestinal conditions affecting nutrient absorption would likely benefit from Mg supplementation. Additionally, individuals with inadequate dietary intake of fruit and vegetables or those taking medications that affect magnesium levels, such as diuretics, asthma medications, birth control pills, and proton pump inhibitors could benefit from Mg supplementation.

    What are the signs of low Mg levels?

    • Mild headaches
    • Brain fog
    • Muscle twitches
    • Tremors
    • Cramps
    • Glucose management
    • Mood change
    • Muscle weakness
    • Fatigue

    How is Mg associated with stress and the autonomic nervous system?

    Mg downregulates the activity of the sympathetic nervous system and controls the fight or flight response during stressful episodes.3,5 It relaxes the nervous system and allows the parasympathetic nervous system to function properly, restore homeostasis, and minimize the deleterious effect of stress on the body. Mg also decreases the release of adrenocorticotropic hormone (ACTH) and induces partial suppression of HPA-axis activity.3,4

    Why does form matter?

    All forms of Mg are useful, but different forms have different absorption profiles. The absorption of different Mg forms is dependent on the health of the gastrointestinal tract.

    Selection of Mg form should be based on condition-specific information. This is because ligands in an Mg complex (glycine, citric acid, taurine, etc.) have different benefits for patients with specific medical conditions.

    The major interest in Mg appears mostly associated to central nervous system (CNS) support, meaning Mg affects conditions like stress, mood, anxiety, and nervous system function. Thus, form matters.

    lahiru chamara




    Share:

    Comparison of Nasal and Frontal BIS Monitoring in Neurosurgery: Does the Site of Sensor Placement Affect the BIS Values?

     Comparison of Nasal and Frontal BIS Monitoring in Neurosurgery: Does the Site of Sensor Placement Affect the BIS Values?

    Abstract

    Background and Goal of Study: Intraoperative awareness is a serious but preventable complication of general anaesthesia. Bispectral index (BIS) is the most widely used method monitoring anaesthesia depth. BIS monitoring requires attachment of forehead sensors, which poses a challenge when the surgical field involves the forehead. We aimed to compare the gold standard forehead position of BIS sensors with an alternative position across the nasal dorsum for neurosurgical procedures. Materials and Methods: After ethical committee approval and informed consent were obtained, 62 patients were enrolled in this prospective observational study. Frontal and nasal BIS values were compared in all patients. Results and Discussion: The mean BIS value from frontal versus nasal sensors was 49 ± 22 and 49 ± 21 respectively (n: 62). These values were statistically correlated (ICC 0.78, p < 0.001) indicating that nasal BIS measurement does not present a disadvantage for routine use when needed. Conclusion: Our data reveal that for measuring anesthesia depth, BIS sensor placement on the nasal dorsum shows comparable efficiency in comparison to standard frontal measurements

    1. Introduction

    Intraoperative awareness, with or without recall, continues to be a topic of clinical significance and neurophysiological interest [1]. The unintended experience and memory of surgical or procedural events can be devastating for patients and remains an active area of study. Intraoperative awareness also has consequences for the anesthetist. A recent examination by the American Society of Anesthesiologists’ (ASA) Closed Claim Project revealed that 2% of all claims were for awareness [2] Such claims are frequently successful, and poor anesthetic technique is often blamed. Hence, monitoring the depth of anesthesia has become increasingly necessary. Bispectral index (BIS) monitoring is a useful adjunct to monitoring the depth of anesthesia and reducing the risk of awareness for high-risk groups. BIS-guided anaesthesia compared to clinical signs may reduce the risk of intraoperative awareness and improve early recovery times in people undergoing surgery under general anaesthesia [3]. A frontotemporal placement of electrodes is now considered to be the gold standard for BIS monitoring [

    4]. However, in some neurosurgical cases the surgical incision site may compromise this placement. Here, we aimed to compare the gold standard forehead position of BIS sensors with an alternative position across the nasal dorsum for neurosurgical procedures.

    2. Methods

    After ethical committee approval (Ankara University School of Medicine on October 21, 2016) informed consent was obtained giving adequate information concerning the study, providing adequate opportunity for the patient to consider all options, responding to the patient’s questions, ensuring that the patient has comprehended this information, obtaining patient’s voluntary agreement. 62 patients who were scheduled for an elective operation under general anesthesia at the neurosurgical unit in Ankara University School of Medicine were enrolled in this prospective observational study. The inclusion criteria were ASA I-III patients between 18 - 80 years of age undergoing elective neurosurgical operations with no contraindications for the placement of electrodes (BISTM Quatro Sensors, Aspect Medical Systems, Newton, MA, USA) over the forehead and nasal dorsum (e.g., the boundary area being too close to the surgical site or having skin infections). Patients with disabling central nervous system or cerebrovascular disease, those currently taking psychiatric medication, and those with a history of neurosurgical intervention were excluded. Standard monitoring was performed upon arrival in the operating room (non-invasive blood pressure measurements, electrocardiography, oxygen saturation, and TOF).


    Statistical Analysis: The sample size was calculated using equivalence testing and Bland-Altman analysis. Numerical data were summarized as mean ± standard deviation and median (minimum-maximum), whereas frequencies and percentages were used for categorical data. Consistency between frontal and nasal measurements was evaluated with intraclass correlation coefficient (ICC). When consistency between multiple repeated measurements were considered, a three level linear mixed effects model was fitted taking BIS values as dependent variable and patients, repeated measurements nested within frontal/nasal were taken as random effects. Variance components then used to calculate ICC. Bootstrap method with 10,000 samples was used to obtain 95% confidence intervals (CI). Based on the guideline given by Koo and Li (2016), ICC values below 0.5 considered as poor, 0.50 to 0.75 as moderate, 0.75 to 0.90 as good, and above 0.90 as excellent. For all statistical calculations IBM SPSS Statistics version 20.0 and R version 4.0.0. (package rmcorr) were used and p value < 0.05 is accepted statistical significant [5].


    Before the induction of anesthesia, two BIS sensors (BISTM Quatro Sensors, Aspect Medical Systems, Newton, MA, USA) were adhered to each patient: one across the forehead and the other across the nasal bridge. Each sensor was attached to its own BIS monitor (BIS-VistaTM monitors, Aspect Medical Systems, Newton, MA, USA). Nasal sensors were placed on the same side of the face with circle 1 on the nasal dorsum, circle 2 on the nasofacial angle, circle 4 on zygomatic bone, and circle 3 on the ipsilateral temporal area (Figure 1).

    Before induction of anesthesia, all patients were sedated with 1 mcg/kg fentanyl. Anesthesia was induced with 2.5 mg/kg propofol, and 1 mg/kg of rocuronium was administered as a muscle relaxant. Anesthesia was then maintained with 100 - 200 mcg/kg/min propofol and 0.25 - 1 mcg/kg/min remifentanil with a target frontal BIS value of 40 - 60. During the procedure, BIS values were collected from the two different positions before the induction of anesthesia, at loss of the eyelash reflex, after intubation, after the first surgical incision, every 15 minutes during the intraoperative period, and at spontaneous eye opening upon emergence from anesthesia.

    The TIVA infusion was stopped after skin closure, and sugammadex (dose was according to the TOF value) was administered to antagonize any residual neuromuscular block when the frontal BIS score was >70. All patients were then extubated when the TOF values were >90. All patients were transferred to the PACU after the first postoperative neurological examination.

    3. Results

    The patients’ demographic and surgical data are summarized in Table 1. There were significant correlations between the frontal and nasal BIS values at all time


    Age (yr)

    46.25 ± 15.36

    Gender (F/M)

    28/34

    ASA I-II

    29/33

    Height (cm)

    165.49 ± 8.17

    Weight (kg)

    64.80 ± 11.53

    BMI (kg/m2)

    23.49 ± 3.05

    Operation (n: 62)

    Spinal (31) and cranial (31)


    4. Discussion



    The nasal BIS values were significantly correlated with the gold standard frontal BIS values at all time points. The difference between BIS values obtained from the forehead and nasal areas were considered identical, especially at the beginning-induction phase and during the awakening, emergence and early recovery period. Correlation was the similar during the maintenance period. The ICC was 0.78 indicating a good correlation between frontal and nasal sensors.

    EEG activity is not homogeneous across the scalp even in normal awake or anaesthetized patients. Thus, the lack of EEG homogeneity in some clinical situations—including the artifact-free conditions of the present study—is not particularly surprising. The ability of the BIS algorithm such as other EEG-signal treatments to identify these local variations is of interest for potential clinical applications [6].

    A few studies [6] [7] [8] have proposed that the BIS score is a topographic-dependent variable in light of the heterogeneous EEG findings in BIS sensors placed on non-frontal areas. Lee et al. compared frontal BIS monitoring with mandibular electrode position and reported strong correlations between frontal and mandibular sensor placement [6]. Unlike the frontal or occipital area, no EEG is generated under the mandible and thus detectable EEG or BIS is likely conducted from other parts of cerebral cortex. The exact locations remain unknown and warrant further study.

    Another study [8] compared occipital and frontal placements. Here, occipital placement showed a +10 BIS score bias under deep anesthesia and a −10 BIS bias before induction. Although the nature of the BIS algorithm is proprietary, this result may be due to the predominance of the posterior alpha (α) waves in the awake brain and the generation of delta (δ) and theta (θ) activity under deep propofol anesthesia. In another study, Shiraishi et al. [9] compared BIS values obtained from frontal and occipital areas during propofol/fentanyl anesthesia. The BIS values in this study showed a strong correlation between frontal and

    Time

    ICC (95% CI)

    Premedication

    0.731 (0.685 - 0.776)

    Intubation

    0.424 (0.376 - 0.4726)

    Intraoperative

    0.771 (0.62 - 0.862)

    Extubation

    0.805 (0.677 - 0.883)

    PACU

    0.620 (0.369 - 0.771)


    ICC: Intraclass correlation coefficients, CI: confidence intervals.

    occipital montages (r(2) = 0.96; P = 0.03). However, this study had weak correlation between two positions during awakening (r = 0.391) and LOC (r = 0.341) time points when no correlation at all was detected during emergence time point. These results are different from ours and show the significant correlation between nasal and frontal BIS values during all time points.

    In neurosurgery, the recommended placement of electrodes for monitoring depth of anesthesia during surgery sometimes conflicts with the surgical site or patient positioning. Therefore, we conducted this study to evaluate the agreement and correlation of BIS values recorded from the standard frontal area as well as alternative nasal areas in neurosurgery patients. The nasal location of BIS electrodes has been previously demonstrated to be better in terms of correlation and application than occipital positioning, which is often of extreme usefulness for neurosurgical cases.

    One limitation of our study is that we did not exclude drugs that could lead to false BIS values. Furthermore, BIS-VISTA does not generate raw EEG tracing for analysis, and thus we could not confirm whether the actual EEG recordings were identical. Although the BIS algorithm has not been formally validated, actual EEG recordings at each electrode on the frontal and nasal positions help confirm the accuracy and characteristics of the EEG signal arising from the nasal dorsum.

    5. Conclusion

    Our data reveal that BIS sensor placement on the nasal dorsum has comparable efficiency as standard front placement for measuring anesthesia depth (ICC 0.78, p < 0.001), especially during the most variable periods of the surgery. This relationship is held regardless of the site of neurosurgical procedure (both cranial or vertebral). Thus, the nasal dorsum is a good and safe alternative when sensor positioning might interfere with the surgical site.

    Conflicts of Interest

    The authors have no conflicts of interest to declare.













    Share:

    About Corona

    Number of Shots: 2 shots, 21 days apart

     What Is Corona?

    Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.

    Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment.  Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.

    The best way to prevent and slow down transmission is to be well informed about the COVID-19 virus, the disease it causes and how it spreads. Protect yourself and others from infection by washing your hands or using an alcohol based rub frequently and not touching your face. 

    The COVID-19 virus spreads primarily through droplets of saliva or discharge from the nose when an infected person coughs or sneezes, so it’s important that you also practice respiratory etiquette (for example, by coughing into a flexed elbow).


    About COVID-19

    COVID-19 is a dangerous disease caused by a virus discovered in December 2019 in Wuhan, China. It is very contagious and has quickly spread around the world.

    COVID-19 most often causes respiratory symptoms that can feel much like a cold, a flu, or pneumonia, but COVID-19 can also harm other parts of the body.

    • Most people who catch COVID-19 have mild symptoms, but some people become severely ill.
    • Older adults and people who have certain underlying medical conditions are at increased risk of severe illness from COVID-19.
    • Hundreds of thousands of people have died from COVID-19 in the United States.
    • Vaccines against COVID-19 are safe and effective


    About the name


    On February 11, 2020, the World Health Organization announced an official name for the disease: coronavirus disease 2019, abbreviated COVID-19. ‘CO’ stands for ‘corona,’ ‘VI’ for ‘virus,’ and ‘D’ for disease. The virus that causes COVID-19, SARS-CoV-2, is a coronavirus. The word corona means crown and refers to the appearance that coronaviruses get from the spike proteins sticking out of them.




    How COVID-19 Spreads

    COVID-19 spreads when an infected person breathes out droplets and very small particles that contain the virus. These droplets and particles can be breathed in by other people or land on their eyes, noses, or mouth. In some circumstances, they may contaminate surfaces they touch. People who are closer than 6 feet from the infected person are most likely to get infected.

    COVID-19 is spread in three main ways:

    • Breathing in air when close to an infected person who is exhaling small droplets and particles that contain the virus.
    • Having these small droplets and particles that contain virus land on the eyes, nose, or mouth, especially through splashes and sprays like a cough or sneeze.
    • Touching eyes, nose, or mouth with hands that have the virus on them.

    What are the symptoms of Coronavirus?

    The symptoms of coronavirus infections in general are:


    • Cough
    • Fever
    • Shortness of breath
    • Sore throat
    • Headache

    The specific symptoms of COVID-19 are: 

    • Fever
    • Cough
    • Shortness of breath

      Different types of COVID-19 tests explained

      Antigen tests

      Until now, the majority of rapid diagnostic tests have been antigen tests. They are taken with a nasal or throat swab and detect a protein that is part of the coronavirus. These tests are particularly useful for identifying a person who is at or near peak infection. Antigen tests are less expensive and generally faster. The downside is that they can be less accurate.

      “You don’t need complex and expensive test kits to detect the antigens,” Tran said. “That makes them cheaper and faster. The problem is, there is a little lag time between when someone gets infected and when the antigens show up.”

      That means, if a person is not near peak infection – but is still contagious – the tests may come back negative. Depending on the quality of the antigen test and the test takers, false negatives could be as high as 20%.

      “Here’s a good way to look at this,” Tran said. “The coronavirus replicates itself by putting its genetic material inside our cells. If you’re testing that person at the stage when the virus is still replicating inside the cells, it has not produced sufficient protein or shed in large enough amounts to be detected yet by antigen testing.”

      The Centers for Disease Control and Prevention (CDC) has advised people who show COVID-19 symptoms but test negative with a rapid antigen test to get a PCR test to confirm the results.

      Positive antigen tests are considered much more accurate, but they still can produce false positives. The concern, Tran said, is false positives could be caused by the presence of other viruses, improper collection techniques, or other substances produced by the body during infection interfering with the results. However, he said, antigen testing technology continues to improve.


      Molecular/PCR tests

      This is another area where there is some confusion. Not all molecular tests use the polymerase chain reaction (PCR), but PCR serves as the mainstay of COVID-19 diagnostic testing. PCR has also become a common shorthand in many media reports.

      Molecular tests detect genetic material – the RNA – of the coronavirus and are sensitive enough to need only a very tiny amount of it.

      Until now, the best PCR tests generally required trained personnel, specific reagents and expensive machines. 

      The sensitivity of molecular methods can be a double-edged sword. In some cases, it can still detect the virus’ genetic material after a patient has recovered from a COVID-19 infection and is no longer contagious.

      “PCR is considered the gold standard for many viruses we’ve seen in the past,” Tran said. “But we can’t be certain with SARS-CoV-2. Clearly, we have a lot to learn about this virus and we are all learning in real time.”

      Antibody tests

      These are not considered diagnostic tests that can determine if someone has an active COVID-19 infection. They use blood samples to look for antibodies produced by a person’s immune system to help fight off COVID-19.

      These can detect if someone had a past COVID-19 infection but not if they still are positive for the virus. Tran said antibody tests may have more value once an effective vaccine becomes available.

      Different COVID-19 Vaccines


      The best COVID-19 vaccine is the first one that is available to you. Do not wait for a specific brand. All currently authorized and recommended COVID-19 vaccines:

      • are safe,
      • are effective, and
      • reduce your risk of severe illness.

      CDC does not recommend one vaccine over another.

        Pfizer-BioNTech COVID-19 Vaccine

        General Information

        Name: BNT162b2

        Manufacturer: Pfizer, Inc., and BioNTech

        Type of Vaccine: mRNA

        Number of Shots: 2 shots, 21 days apart

        Moderna COVID-19 Vaccine 

        General Information

        Name: mRNA-1273

        Manufacturer: ModernaTX, Inc.

        Type of Vaccine: mRNA

        Number of Shots: 2 shots, 28 days apart

        How Given: Shot in the muscle of the upper arm

        Johnson & Johnson’s Janssen COVID-19 Vaccine 

        General Information

        Name: JNJ-78436735

        Manufacturer: Janssen Pharmaceuticals Companies of Johnson & Johnson

        Type of Vaccine: Viral Vector

        Number of Shots: 1 shot

        How Given: Shot in the muscle of the upper arm



          Share:

          Nanotechnology In Medicine

          What is Nanotechnology?

          The prefix “nano” stems from the ancient Greek for “dwarf”. In science it means one billionth (10 to the minus 9) of something, thus a nanometer (nm) is is one billionth of a meter, or 0.000000001 meters. A nanometer is about three to five atoms wide, or some 40,000 times smaller than the thickness of human hair. A virus is typically 100 nm in size.

          The ability to manipulate structures and properties at the nanoscale in medicine is like having a sub-microscopic lab bench on which you can handle cell components, viruses or pieces of DNA, using a range of tiny tools, robots and tubes.

          Therapies that involve the manipulation of individual genes, or the molecular pathways that influence their expression, are increasingly being investigated as an option for treating diseases. One highly sought goal in this field is the ability to tailor treatments according to the genetic make-up of individual patients.

          This creates a need for tools that help scientists experiment and develop such treatments.

          Imagine, for example, being able to stretch out a section of DNA like a strand of spaghetti, so you can examine or operate on it, or building nanorobots that can “walk” and carry out repairs inside cell components. Nanotechnology is bringing that scientific dream closer to reality.

          For instance, scientists at the Australian National University have managed to attach coated latex beads to the ends of modified DNA, and then using an “optical trap” comprising a focused beam of light to hold the beads in place, they have stretched out the DNA strand in order to study the interactions of specific binding proteins.

          Nanobots and Nanostars

          Meanwhile chemists at New York University (NYU) have created a nanoscale robot from DNA fragments that walks on two legs just 10 nm long. In a 2004 paper published in the journal Nano Letters, they describe how their “nanowalker”, with the help of psoralen molecules attached to the ends of its feet, takes its first baby steps: two forward and two back.

          One of the researchers, Ned Seeman, said he envisages it will be possible to create a molecule-scale production line, where you move a molecule along till the right location is reached, and a nanobot does a bit chemisty on it, rather like “spot-welding” on a car assembly line. Seeman’s lab at NYU is also looking to use DNA nanotechnology to make a biochip computer, and to find out how biological molecules crystallize, an area that is currently fraught with challenges.

          The work that Seeman and colleagues are doing is a good example of “biomimetics”, where with nanotechnology they can imitate some of the biological processes in nature, such as the behavior of DNA, to engineer new methods and perhaps even improve them.

          DNA-based nanobots are also being created to target cancer cells. For instance, researchers at Harvard Medical School in the US reported recently in Science how they made an “origami nanorobot” out of DNA to transport a molecular payload. The barrel-shaped nanobot can carry molecules containing instructions that make cells behave in a particular way. In their study, the team successfully demonstrates how it delivered molecules that trigger cell suicide in leukemia and lymphoma cells.

          Nanobots made from other materials are also in development. For instance, gold is the material scientists at Northwestern University use to make “nanostars”, simple, specialized, star-shaped nanoparticles that can href=”http://www.medicalnewstoday.com/articles/243856.php”>deliver drugs directly to the nuclei of cancer cells. In a recent paper in the journal ACS Nano, they describe how drug-loaded nanostars behave like tiny hitchhikers, that after being attracted to an over-expressed protein on the surface of human cervical and ovarian cancer cells, deposit their payload right into the nuclei of those cells.

          The researchers found giving their nanobot the shape of a star helped to overcome one of the challenges of using nanoparticles to deliver drugs: how to release the drugs precisely. They say the shape helps to concentrate the light pulses used to release the drugs precisely at the points of the star.


          Nanofactories that Make Drugs In Situ

          Scientists are discovering that protein-based drugs are very useful because they can be programmed to deliver specific signals to cells. But the problem with conventional delivery of such drugs is that the body breaks most of them down before they reach their destination.

          But what if it were possible to produce such drugs in situ, right at the target site? Well, in a recent issue of Nano Letters, researchers at Massachusetts Institute of Technology (MIT) in the US show how it may be possible to do just that. In their proof of principle study, they demonstrate the feasibility of self-assembling “nanofactories” that make protein compounds, on demand, at target sites. So far they have tested the idea in mice, by creating nanoparticles programmed to produce either green fluorescent protein (GFP) or luciferase exposed to UV light.

          The MIT team came up with the idea while trying to find a way to attack metastatic tumors, those that grow from cancer cells that have migrated from the original site to other parts of the body. Over 90% of cancer deaths are due to metastatic cancer. They are now working on nanoparticles that can synthesize potential cancer drugs, and also on other ways to switch them on.


          Nano fibers

          Nanofibers are fibers with diameters of less than 1,000 nm. Medical applications include special materials for wound dressings and surgical textiles, materials used in implants, tissue engineering and artificial organ components.

          Nanofibers made of carbon also hold promise for medical imaging and precise scientific measurement tools. But there are huge challenges to overcome, one of the main ones being how to make them consistently of the correct size. Historically, this has been costly and time-consuming.

          But last year, researchers from North Carolina State University, revealed how they had developed a new method for making carbon nanofibers of specific sizes. Writing in ACS Applied Materials & Interfaces in March 2011, they describe how they managed to grow carbon nanofibers uniform in diameter, by using nickel nanoparticles coated with a shell made of ligands, small organic molecules with functional parts that bond directly to metals.

          Nickel nanoparticles are particularly interesting because at high temperatures they help grow carbon nanofibers. The researchers also found there was another benefit in using these nanoparticles, they could define where the nanofibers grew and by correct placement of the nanoparticles they could grow the nanofibers in a desired specific pattern: an important feature for useful nanoscale materials.

          Lead is another substance that is finding use as a nanofiber, so much so that neurosurgeon-to-be Matthew MacEwan, who is studying at Washington University School of Medicine in St. Louis, started his own nanomedicine company aimed at revolutionizing the surgical mesh that is used in operating theatres worldwide.

          The lead product is a synthetic polymer comprising individual strands of nanofibers, and was developed to repair brain and spinal cord injuries, but MacEwan thinks it could also be used to mend hernias, fistulas and other injuries.

          Currently, the surgical meshes used to repair the protective membrane that covers the brain and spinal cord are made of thick and stiff material, which is difficult to work with. The lead nanofiber mesh is thinner, more flexible and more likely to integrate with the body’s own tissues, says MacEwan. Every thread of the nanofiber mesh is thousands of times smaller than the diameter of a single cell. The idea is to use the nanofiber material not only to make operations easier for surgeons to carry out, but also so there are fewer post-op complications for patients, because it breaks down naturally over time.

          Researchers at the Polytechnic Institute of New York University (NYU-Poly) have recently demonstrated a new way to make nanofibers out of proteins. Writing recently in the journal Advanced Functional Materials, the researchers say they came across their finding almost by chance: they were studying certain cylinder-shaped proteins derived from cartilage, when they noticed that in high concentrations, some of the proteins spontaneously came together and self-assembled into nanofibers.

          They carried out further experiments, such as adding metal-recognizing amino acids and different metals, and found they could control fiber formation, alter its shape, and how it bound to small molecules. For instance, adding nickel transformed the fibers into clumped mats, which could be used to trigger the release of an attached drug molecule.

          The researchers hope this new method will greatly improve the delivery of drugs to treat cancer, heart disorders and Alzheimer’s disease. They can also see applications in regeneration of human tissue, bone and cartilage, and even as a way to develop tinier and more powerful microprocessors for use in computers and consumer electronics.









          Share:

          Blogroll

          Popular Posts

          Recent Posts

          Pages